QUINAGOLIDE VAGINAL RING FOR ENDOMETRIOSIS: RESULTS FROM THE CLINICAL PHASE 1 PROGRAM
article
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
This Phase 1 program evaluated the safety, tolerability, and pharmacokinetics of a quinagolide vaginal ring in healthy women to assess its potential for endometriosis treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (3)
- Use of dopamine agonists to target angiogenesis in women with endometriosis 2020
- State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials 2022
- A Comprehensive Review of the Efficacy and Safety of Dopamine Agonists for Women with Endometriosis-associated Infertility from Inception to July 31, 2022 2023
Cited by (3)
- A Comprehensive Review of the Efficacy and Safety of Dopamine Agonists for Women with Endometriosis-associated Infertility from Inception to July 31, 2022 2023
- State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials 2022
- Use of dopamine agonists to target angiogenesis in women with endometriosis 2020
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0
· commercial use OK